Indian Journal of Economics and Development

Open Access Open Access  Restricted Access Subscription Access

The Impact of World Trade Organization’s TRIPS Agreement on Access to Essential Medicine in Nigeria: Apolitical Economy Analysis


Affiliations
1 Department of Political Science, University of Ilorin, Nigeria
2 Department of Economics, Gombe State University, Nigeria
 

Background/Objectives: In view of the trade-off, this paper sought to delve into the implications of TRIPs agreement on access to essential medicines in Nigeria.

Methods/Statistical Analysis: Data from World Bank and World Health Organization were used in the paper. The study adopted some techniques of descriptive analysis like charts and tables in accomplishing its objectives.

Findings: The study came up with the following findings. First, a great number of people living with diseases lack access to essential medicines and the figures are rather increasing on daily basis, thereby resulting in the death of millions of people, due to TRIPs. Second, TRIPs agreement might be seen as a strategic tool used in maintaining and perpetuating developing countries’ dependency on developed world. Third, other factors like distribution challenges, information gap (lack of awareness), and social factors (like stigmatization) are playing subservient roles in restricting people from accessing essential medicines even though some of the medicines are provided free of charge.

Applications: The study recommended that TRIPs agreement should be reviewed; there should be a public-private partnership in the provisioning of the essential medicines; and bridge information gap through awareness creation.


Keywords

Essential Medicines, TRIPs Agreement, Human Rights, Trade-Off and WTO.
User
Notifications

  • Universal Declaration of Human Rights 1948.https://www.humanrights.ch/en/standards/udhr/. Date accessed: 19/08/2011.

  • World Health Organization. The Essential Drugs Strategy. Geneva: WHO. 2000; 1-81.

  • United Nations, (UN). Conference on Trade and Development. Dispute Settlement. New York and Geneva: UN. 2003; 1-184.

  • J. Watal. Access to essential medicines in developing countries: Does the WTO TRIPS agreement hinder it? Cambridge, MA, USA: Center for International Development, Harvard University. 2000.

  • P. Cullet. Patent and medicines: the relationship between TRIPS and Human Rights to health. Journal of International Affairs. 2003; 79(1), 139-160.

  • World Trade Organization. TRIPS and Pharmaceutical Patent. New York: WTO. 2003.

  • K.G. Kingston. The implications of ‘TRIPS’ Agreement 1994 of the World Trade Organization for the developing countries. African Journal of Social Sciences. 2011; 1, 37-64.

  • W. Simpson, M. Brown. Advocates for International Development: Lawyers Eradicating Poverty. Oxford: Oxford University Press. 2012.

  • M. Matsuhita, T. Schoenbaum, P.C. Mavroidis. World Trade Organization: Law, Practice and Policy. Oxford University Press. 2003.

  • World Health Organization. Global Health Indicators. Geneva: WHO. 2015.

  • Federal Republic of Nigeria. Constitution of the Federal Republic of Nigeria. Abuja: FRN. 1999.

  • National Agency for the Control of AIDS. Global AIDS Response: Country Progress Report Nigeria GARPR. Abuja: NACA. 2015; 1-66.

  • World Development Indicators. New York: World Bank. 2015.

  • World Health Organization. Global Health Indicators. Geneva: WHO. 2015; 1-121.

  • C. Thomas. Trade policy and politics of access to drugs. Carfax Publishing, Taylor and Francis Group. Third World Quarterly. 2002; 23, 251-264.

  • A. Lanoszka. The global polities of intellectual property rights and pharmaceutical drugs policies in developing countries, London: SAGE Publications. International Political Science Review. 2003; 24(2), 181-197.

  • A.J. Anderson. Global pharmaceutical patent law in developing countries amending trips to promote access for all. The Berkeley Electronic Press. Be press Legal Series. 2006; 1-48.

  • Z.A. Zainol. Pharmaceutical patents and access to essential medicines in sub Saharan Africa. African Journal of Biotechnology. 2011; 10, 12376-12388.

  • M. McClellan. The TRIPS agreement and the human rights to essential medicines. Access to AIDS Medicines. New York. 2005; 12(1), 1-25.

  • World Trade Organization. Agreement on trade related aspects of intellectual property rights. Geneva: WTO. 2004; 1-15.

  • World Intellectual Property Organization. WIPO Intellectual Handbook. Geneva: WIPO. 2004.

  • TRIPS and pharmaceutical patents. WTO, OMC. Fact Sheet. Geneva: World Trade Organization. 2006; 1-8.

  • Access to medicines: pricing and procurement practices. https://www.wto.org/english/tratop_e/trips_e/techsymp_july10_e/techsymp_july10_e.htm. Date accessed: 22/07/2010.

  • TRIPS Issues Geographical Indications: Papers Circulated in the Negotiations.https://www.wto.org/english/tratop_e/trips_e/gi1_docs_e.htm. Date accessed: 11/2008.

  • M.P. Todaro, S.C. Smith. Economic Development (11th edition). Essex: Pearson Education Limited. 2011.

  • V. Randall, R. Theobald. Political change and underdevelopment: A critical Introduction to Third World Politics. Political Science. Durham, North Carolina: Duke University Press. 1985; 1-294.

  • Neo-Marxist Dependency Theories: Dependency and under development in the Third World Countries. www.meteck.org/dependency.html. Date accessed: 12/2002.

  • I.V. Ferraro. Dependency theory: An introduction. South Hadley Mount Holyoke College. 1996; 1-22.

  • A.A. Adewole. Globalization, the TRIPS agreement and their implications on access to essential medicines for developing countries: A case study of Nigeria. NIALS Law and Development Journal. 2010; 171-192.

  • J.R. Borrell, J. Watal. Impact of patents on access to HIV/AIDS drugs in developing countries. Preliminary Version, Center for International Development at Harvard University. 2003; 1-35.

  • Federal Ministry of Health (FMoH).Medicine Prices in Nigeria: Price People Pay for Medicines. Abuja: FMoH. 2006; 1-71.


Abstract Views: 262

PDF Views: 186




  • The Impact of World Trade Organization’s TRIPS Agreement on Access to Essential Medicine in Nigeria: Apolitical Economy Analysis

Abstract Views: 262  |  PDF Views: 186

Authors

Muhammad Yusuf
Department of Political Science, University of Ilorin, Nigeria
Musa Abdu
Department of Economics, Gombe State University, Nigeria

Abstract


Background/Objectives: In view of the trade-off, this paper sought to delve into the implications of TRIPs agreement on access to essential medicines in Nigeria.

Methods/Statistical Analysis: Data from World Bank and World Health Organization were used in the paper. The study adopted some techniques of descriptive analysis like charts and tables in accomplishing its objectives.

Findings: The study came up with the following findings. First, a great number of people living with diseases lack access to essential medicines and the figures are rather increasing on daily basis, thereby resulting in the death of millions of people, due to TRIPs. Second, TRIPs agreement might be seen as a strategic tool used in maintaining and perpetuating developing countries’ dependency on developed world. Third, other factors like distribution challenges, information gap (lack of awareness), and social factors (like stigmatization) are playing subservient roles in restricting people from accessing essential medicines even though some of the medicines are provided free of charge.

Applications: The study recommended that TRIPs agreement should be reviewed; there should be a public-private partnership in the provisioning of the essential medicines; and bridge information gap through awareness creation.


Keywords


Essential Medicines, TRIPs Agreement, Human Rights, Trade-Off and WTO.

References